CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)

Documenti analoghi

• CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
  di: Khan Sarah N, et al.
  Pubblicazione: (2013-01-01)
• CEMRA in neonatal and pediatric congenital vascular diseases at 1.5T and 3.0T: comparison of an intravascular contrast agent (Gadofosveset) with an extracellular agent (Gadopentetate Dimeglumine)
  di: Khan, SN, et al.
  Pubblicazione: (2013)
• Gadopentetate Dimeglumine as a Contrast Agent in Common Carotid Arteriography
  di: Erly, William K., et al.
  Pubblicazione: (2000)
• 3.0-T Whole-Heart Coronary Magnetic Resonance Angiography: Comparison of Gadobenate Dimeglumine and Gadofosveset Trisodium
  di: Raman, Fabio S, et al.
  Pubblicazione: (2013)
• Visualization of Chronic Myocardial Infarction Using the Intravascular Contrast Agent MS-325 (Gadofosveset) in Patients
  di: Thouet, Thomas, et al.
  Pubblicazione: (2012)